Analisi retrospettiva dei costi e di outcome sanitari in pazienti affetti da asma grave in un contesto real-world: il caso di studio benralizumab.

Copyright of Giornale Italiano di Health Technology Assessment Delivery is the property of Springer Healthcare Italia Srl and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)